3

OWNERSHIP DOCUMENT

Company: Barinthus Biotherapeutics plc.
Filed: April 29, 2021
Period of Report: April 29, 2021
Accession Number: 0001104659-21-057858

View Document ↗ View on SEC.gov ↗